文献速递结核与非结核分枝杆菌

血浆代谢特征用于诊断肺结核并监测治疗反应

A Plasma Metabolic Signature to Diagnose Pulmonary Tuberculosis and Monitor Treatment Response.
PubMed 文献 · J Infect Dis · 2025-01-01

研究基于埃塞俄比亚肺结核患者诊断时血浆(n=82)与有TB症状的家庭接触者(n=104)比较,并在治疗2、6、12个月后随访,另用格鲁吉亚(n=89)和南非(n=85)独立队列验证。包含Kyn/Trp比值和视黄醇的特征对TB病分类AUC=0.97,南非HIV阳性者AUC=0.97、HIV阴性者AUC=0.95,格鲁吉亚TB患者AUC=0.93。埃塞俄比亚参与者特征评分在治疗2个月(0.85降至0.42)和6个月(0.42降至0.18)后下降(均P<.0001),降至与对照相似水平。

要点

  • Kyn/Trp比值联合视黄醇的血浆代谢特征对肺结核分类AUC达0.97。
  • 该特征在南非HIV阳性(AUC=0.97)和HIV阴性(AUC=0.95)TB患者中均表现良好。
  • 埃塞俄比亚参与者特征评分在治疗2个月和6个月后显著下降至对照水平。

核心结论

  • 血浆Kyn/Trp比值和视黄醇构成有前景的代谢特征,可能推进TB诊断。

研究设计与样本

  • 研究比较埃塞俄比亚肺结核患者诊断时血浆(n=82)与有TB症状的家庭接触者(n=104),并在治疗2、6、12个月后随访。
  • 参与者分为训练集和测试集建模,另用格鲁吉亚(n=89)和南非(n=85)独立队列验证。
  • 特征还在感染Mtb的非人灵长类中进一步评估。

主要发现

  • TB病患者色氨酸(Trp)和视黄醇浓度显著降低(45.2 vs 62.5 μM和4.1 vs 8.2 μM),犬尿氨酸(Kyn)显著升高(2.1 vs 1.6 μM;q < .0001)。
  • 包含Kyn/Trp比值和视黄醇的特征对TB病分类AUC=0.97。
  • 该特征在南非HIV阳性TB病患者中AUC=0.97、HIV阴性者AUC=0.95,格鲁吉亚TB患者AUC=0.93。
  • 埃塞俄比亚参与者特征评分在治疗2个月(0.85降至0.42)和6个月(0.42降至0.18)后下降(均P<.0001),降至与对照相似水平。
  • 感染Mtb的非人灵长类在感染后15-16周血浆视黄醇下降(5.9 vs 3.6 μM;P < .001)。

临床怎么用

  • 血浆Kyn/Trp比值和视黄醇特征可能用于辅助诊断肺结核并监测治疗反应。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High-resolution metabolomics has shown promise for identifying blood-based biomarkers of tuberculosis (TB). We sought to discover a metabolic signature to detect pulmonary TB disease and monitor treatment response. METHODS: Plasma from Ethiopian persons with pulmonary TB at diagnosis (n = 82) was compared to household contacts with TB symptoms (n = 104) and 2, 6, and 12 months after treatment initiation. Participants were divided into training and test sets for model building, with additional validation using independent cohorts from the countries of Georgia (n = 89) and South Africa (n = 85). Signatures were further evaluated in nonhuman primates infected with Mycobacterium tuberculosis (Mtb). RESULTS: Among the metabolites that most significantly differed in concentration, tryptophan (Trp) and retinol were significantly decreased in persons with TB disease (45.2 vs 62.5 μM and 4.1 vs 8.2 μM, respectively), while kynurenine (Kyn) was significantly increased (2.1 vs 1.6 μM; q < .0001 for all). A signature that included the Kyn/Trp ratio and retinol showed excellent classification for TB disease (area under the curve [AUC] = 0.97). The signature had an AUC of 0.97 in HIV-positive and 0.95 in HIV-negative persons with TB disease from South Africa and 0.93 in TB patients from Georgia. In Ethiopian participants, signature scores decreased after 2 months (0.85 to 0.42) and 6 months of TB treatment (0.42 to 0.18; P < .0001 for both) to similar levels as controls. Plasma retinol also declined in nonhuman primates infected with Mtb 15-16 weeks after infection (5.9 vs 3.6 μM; P < .001). CONCLUSIONS: The plasma Kyn/Trp ratio and retinol represents a promising metabolic signature that could advance TB diagnostics.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Collins JM, Bobosha K, Narayanan N, et al. A Plasma Metabolic Signature to Diagnose Pulmonary Tuberculosis and Monitor Treatment Response. J Infect Dis. 2025. PMID: 40338044. doi:10.1093/infdis/jiaf240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。